A eukaryotic transcriptional repressor with carboxypeptidase activity
about
Regulation of IkappaBalpha function and NF-kappaB signaling: AEBP1 is a novel proinflammatory mediator in macrophagesIdentification and characterization of three members of the human metallocarboxypeptidase gene familyDNA and RNA binding by the mitochondrial lon protease is regulated by nucleotide and protein substrateCloning and expression of human carboxypeptidase Z, a novel metallocarboxypeptidaseSequence of human carboxypeptidase D reveals it to be a member of the regulatory carboxypeptidase family with three tandem active site domainsEnzymic characterization of a novel member of the regulatory B-like carboxypeptidase with transcriptional repression function: stimulation of enzymic activity by its target DNAImpaired abdominal wall development and deficient wound healing in mice lacking aortic carboxypeptidase-like proteinPPARgamma1 and LXRalpha face a new regulator of macrophage cholesterol homeostasis and inflammatory responsiveness, AEBP1Structural basis for DNA-mediated allosteric regulation facilitated by the AAA+ module of Lon proteaseCloning and characterization of a novel zinc finger transcriptional repressor. A direct role of the zinc finger motif in repressionGlu300 of rat carboxypeptidase E is essential for enzymatic activity but not substrate binding or routing to the regulated secretory pathwayAEBP1 upregulation confers acquired resistance to BRAF (V600E) inhibition in melanomaElucidation of CPX-1 involvement in RANKL-induced osteoclastogenesis by a proteomics approach.Endoribonuclease L (RNase L) regulates the myogenic and adipogenic potential of myogenic cellsEpiregulin enhances tumorigenicity by activating the ERK/MAPK pathway in glioblastoma.Carboxypeptidases in disease: insights from peptidomic studies.Carboxypeptidase Z is present in the regulated secretory pathway and extracellular matrix in cultured cells and in human tissues.Leptin-specific patterns of gene expression in white adipose tissue.Lactation defect with impaired secretory activation in AEBP1-null mice.Characterization of Drosophila carboxypeptidase D.The action of D-dopachrome tautomerase as an adipokine in adipocyte lipid metabolismIntrinsic depot-specific differences in the secretome of adipose tissue, preadipocytes, and adipose tissue-derived microvascular endothelial cellsRegulation of adipocyte differentiation.Adipocyte enhancer-binding protein 1 is a potential novel atherogenic factor involved in macrophage cholesterol homeostasis and inflammationThe role of AEBP1 in sex-specific diet-induced obesity.Exploring the key genes and signaling transduction pathways related to the survival time of glioblastoma multiforme patients by a novel survival analysis model.Functional mechanics of the ATP-dependent Lon protease- lessons from endogenous protein and synthetic peptide substrates.The fibromatosis signature defines a robust stromal response in breast carcinoma.Transcriptional control of the pref-1 gene in 3T3-L1 adipocyte differentiation. Sequence requirement for differentiation-dependent suppression.Central (ICV) leptin injection increases bone formation, bone mineral density, muscle mass, serum IGF-1, and the expression of osteogenic genes in leptin-deficient ob/ob mice.Insider trading: Extracellular matrix proteins and their non-canonical intracellular roles.Inhibition of the protease activity of influenza virus RNA polymerase PA subunit by viral matrix protein.Regulation of adipogenesis by a transcriptional repressor that modulates MAPK activation.Ontogeny of prohormone convertases in rat prenatal development.Induced and spontaneous mutations at Ser202 of carboxypeptidase E. Effect on enzyme expression, activity, and intracellular routing.Cellular carboxypeptidases.Mast cell deficiency results in the accumulation of preadipocytes in adipose tissue in both obese and non-obese mice.Adipocyte enhancer-binding protein-1 promotes macrophage inflammatory responsiveness by up-regulating NF-kappaB via IkappaBalpha negative regulation.Adipocyte enhancer-binding protein 1 modulates adiposity and energy homeostasis.Effect of mutation of two critical glutamic acid residues on the activity and stability of human carboxypeptidase M and characterization of its signal for glycosylphosphatidylinositol anchoring.
P2860
Q21296830-2201CE8F-C31B-4417-BE90-D34F5CF57508Q24292275-BCC78D29-22C7-4D02-8D31-13FA39ACB9FAQ24305946-F95C8A11-43AF-49C5-BB8A-591E9E54CC5AQ24312739-E14EBD80-D0CC-4396-920B-0B05A469353BQ24530524-5E6F532E-6EC1-45DD-85B0-520F6C486786Q24531845-2722881A-7B6D-41C5-8201-2A6F1F8C55B4Q24550890-2FD5272A-3C60-4885-97C4-10FB81FF3465Q24633440-2613725B-2D8A-4E1F-9C0B-8D68C5E87B7AQ27689077-CCE34EBA-2E59-4AD1-B984-A41B60EB40AFQ28508072-65AFFAD4-C945-4721-8734-5D3FCFA267FAQ28581024-B6F6B7C5-1B37-4E72-8500-04AEAFC94767Q28661371-779A105A-14B3-446D-8C74-70CC0551D727Q33201894-66ED7B5C-11DF-483E-9F49-A61A77F6B734Q33511996-A85779D8-23C8-4727-B30E-44D772E34A72Q33753468-0DF5BABF-F3E5-45EA-B673-D1A654499330Q33772669-3754BFEA-8ABC-4C8D-8975-ED32040F9EA5Q33889722-791F3DC4-1E93-413E-907C-84EC08AB364AQ33899691-8EE9897F-8E49-4F27-B65B-D24B8451E188Q34082855-FEAB7E70-60E0-4E15-966A-49DD4168DB6CQ34155870-BF639D68-88B6-49E7-9DB4-4817F62D777FQ34200909-E9A00F51-A8C2-43F5-B848-128DAF4D4013Q34355157-CBE6CC0C-C2D4-48D8-9E1F-112EAA2BBBC7Q34454568-58777211-7010-4F6E-985F-50BF29515F50Q34478995-D0014DAF-BCCC-4A81-B290-E2D9E493DFA5Q34572292-EC937321-D263-497C-8816-40A6E239297FQ36280795-E866F035-D884-4CDC-997C-C08FF247867BQ36743161-A240849C-E719-4D11-9A18-28BF313E71CFQ36841980-0A2B5A80-3336-42D5-924E-CFF7025CBC54Q38331211-8745FBF1-BE56-4889-80F8-3770560A0D69Q38335686-FAD8C7CB-0D5D-4B86-99A2-C4E4DA8EE349Q38688202-D700518E-1A3B-45F7-909B-1393AFB85854Q40638142-5B8C9A65-7AC7-411D-B00D-BAC0C2982FDAQ40832320-011D235A-4E67-4BAD-B229-23D45013CC55Q40897181-DB967567-C182-4F3C-82A2-F0E65BC0F261Q41192019-CB56A994-F004-49E8-96A9-288AAEBFB413Q41745113-BC90442A-2F90-4408-A70C-4510B71BC576Q41845118-C4F94F68-5C0C-4514-A5AF-6EA2ECB5ECD1Q42084614-2F58101A-3C94-456B-81B4-D2E59C86E44DQ42508293-C204DCCA-865C-425D-B0D6-E99715B5841FQ43002720-1B925623-9ABF-4F53-8FD1-8E8CBCB6C564
P2860
A eukaryotic transcriptional repressor with carboxypeptidase activity
description
1995 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
article publié dans la revue scientifique Nature
@fr
artículu científicu espublizáu en 1995
@ast
scientific journal article
@en
vedecký článok (publikovaný 1995/11/02)
@sk
vědecký článek publikovaný v roce 1995
@cs
wetenschappelijk artikel (gepubliceerd op 1995/11/02)
@nl
наукова стаття, опублікована в листопаді 1995
@uk
مقالة علمية (نشرت في 2-11-1995)
@ar
name
A eukaryotic transcriptional repressor with carboxypeptidase activity
@ast
A eukaryotic transcriptional repressor with carboxypeptidase activity
@en
A eukaryotic transcriptional repressor with carboxypeptidase activity
@nl
type
label
A eukaryotic transcriptional repressor with carboxypeptidase activity
@ast
A eukaryotic transcriptional repressor with carboxypeptidase activity
@en
A eukaryotic transcriptional repressor with carboxypeptidase activity
@nl
prefLabel
A eukaryotic transcriptional repressor with carboxypeptidase activity
@ast
A eukaryotic transcriptional repressor with carboxypeptidase activity
@en
A eukaryotic transcriptional repressor with carboxypeptidase activity
@nl
P2093
P356
P1433
P1476
A eukaryotic transcriptional repressor with carboxypeptidase activity
@en
P2093
P2888
P356
10.1038/378092A0
P407
P577
1995-11-02T00:00:00Z
P6179
1014005971